Related references
Note: Only part of the references are listed.A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS)
Karien Esterhuizen et al.
MITOCHONDRION (2019)
Exploring mTOR inhibition as treatment for mitochondrial disease
Abigail Sage-Schwaede et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches
Ana K. Rosen Vollmar et al.
METABOLITES (2019)
Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD
Mona M. Khamis et al.
METABOLOMICS (2018)
Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers
Jana Buzkova et al.
EMBO MOLECULAR MEDICINE (2018)
Metabolomics of mitochondrial disease
Karien Esterhuizen et al.
MITOCHONDRION (2017)
Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics
Darrell D. Marshall et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2017)
Molecular Diagnosis of Myoclonus epilepsy associated with Ragged-Red Fibers syndrome in the absence of Ragged Red Fibers
Sun Yeong Park et al.
FRONTIERS IN NEUROLOGY (2017)
Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism
Joni Nikkanen et al.
CELL METABOLISM (2016)
Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism
Adam D. Kennedy et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2016)
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Melissa Carbonneau et al.
NATURE COMMUNICATIONS (2016)
Mitochondrial dysfunction remodels one - carbon metabolism in human cells
Xiaoyan Robert Bao et al.
ELIFE (2016)
When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis?
Paulo Jose Lorenzoni et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Xudong Fu et al.
CELL METABOLISM (2015)
Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed
Andrea Mignarri et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
The urinary proteome and metabonome differ from normal in adults with mitochondrial disease
Andrew M. Hall et al.
KIDNEY INTERNATIONAL (2015)
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options
Ayman W. El-Hattab et al.
MOLECULAR GENETICS AND METABOLISM (2015)
When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis?
Paulo Jose Lorenzoni et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2014)
Mitochondrial genome changes and neurodegenerative diseases
Milena Pinto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
Nahid A. Khan et al.
EMBO MOLECULAR MEDICINE (2014)
Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence
Emma L. Schymanski et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2014)
A guide to diagnosis and treatment of Leigh syndrome
Fabian Baertling et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Metabolic features of the cell danger response
Robert K. Naviaux
MITOCHONDRION (2014)
The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR
Randall M. Chin et al.
NATURE (2014)
Potential metabolite markers of schizophrenia
J. Yang et al.
MOLECULAR PSYCHIATRY (2013)
Disclosure of a putative biosignature for respiratory chain disorders through a metabolomics approach
Izelle Smuts et al.
METABOLOMICS (2013)
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Simon C. Johnson et al.
SCIENCE (2013)
Modern analytical techniques in metabolomics analysis
Aihua Zhang et al.
ANALYST (2012)
Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations
Kenjiro Kami et al.
MITOCHONDRION (2012)
Metabolomics of urinary organic acids in respiratory chain deficiencies in children
Carolus J. Reinecke et al.
METABOLOMICS (2012)
Treatment Options for Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome
Kristin M. Santa
PHARMACOTHERAPY (2010)
Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
Petra Kaufmann et al.
ARCHIVES OF NEUROLOGY (2009)
Lipoic Acid Synthase (LASY) A Novel Role in Inflammation, Mitochondrial Function, and Insulin Resistance
Indira Padmalayam et al.
DIABETES (2009)
Mitochondrial Fatty Acid Synthesis Type II: More than Just Fatty Acids
J. Kalervo Hiltunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Fatty acid oxidation and insulin action - When less is more
Deborah M. Muoio et al.
DIABETES (2008)
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A > G mitochondrial point mutation
R. Murphy et al.
DIABETIC MEDICINE (2008)
Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation
J. Finsterer
ACTA NEUROLOGICA SCANDINAVICA (2007)
Population prevalence of the MELAS A3243G mutation
Neil Manwaring et al.
MITOCHONDRION (2007)
The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome - A review of treatment options
Fernando Scaglia et al.
CNS DRUGS (2006)
Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders
JA Smeitink et al.
CELL METABOLISM (2006)
Endogenous production of lipoic acid is essential for mouse development
XW Yi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis
MM Löwik et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Respiratory chain defects:: what do we know for sure about their consequences in vivo?
JJ Brière et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2004)
Metabolomics - the link between genotypes and phenotypes
O Fiehn
PLANT MOLECULAR BIOLOGY (2002)